RT Journal Article
SR Electronic
T1 Data-driven identification of potentially successful intervention implementations: a proof of concept using five years of opioid prescribing data from over 7000 practices in England
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.28.23291704
DO 10.1101/2023.06.28.23291704
A1 Hopcroft, Lisa E. M.
A1 Curtis, Helen J.
A1 Croker, Richard
A1 Pretis, Felix
A1 Inglesby, Peter
A1 Evans, Dave
A1 Bacon, Seb
A1 Goldacre, Ben
A1 Walker, Alex J.
A1 MacKenna, Brian
YR 2023
UL http://medrxiv.org/content/early/2023/06/29/2023.06.28.23291704.abstract
AB Background We have previously demonstrated that opioid prescribing increased by 127% between 1998 and 2016. New policies aimed at tackling this increasing trend have been recommended by public health bodies and there is some evidence that progress is being made. We sought to extend our previous work and develop an unbiased, data-driven approach to identify general practices and clinical commissioning groups (CCGs) whose prescribing data suggest that interventions to reduce the prescribing of opioids may have been successfully implemented.Methods We analysed five years of prescribing data for three opioid prescribing measures: one capturing total opioid prescribing and two capturing regular prescribing of high dose opioids. Using a data-driven approach, we applied a modified version of our change detection Python library to identify changes in these measures over time, consistent with the successful implementation of an intervention. This analysis was carried out for general practices and CCGs, and organisations were ranked according to the change in prescribing rate.Results We present data for the three CCGs and practices demonstrating the biggest reduction in opioid prescribing across the three opioid prescribing measures. We observed a 40% drop in the regular prescribing of high dose opioids (measured as a percentage of regular opioids) in the highest ranked CCG (North Tyneside); a 99% drop in this same measure was found in several practices. Decile plots demonstrate that CCGs exhibiting large reductions in opioid prescribing do so via slow and gradual reductions over a long period of time (typically over two years); in contrast, practices exhibiting large reductions do so rapidly over a much shorter period of time.Conclusions By applying one of our existing analysis tools to a national dataset, we were able to rank NHS organisations by reduction in opioid prescribing rates. Highly ranked organisations are candidates for further qualitative research into intervention design and implementation.Contributions to the literatureDemonstrating that a data-driven approach can identify and quantify changes in important clinical measures in publicly available NHS dataIdentifying changes in this way allows the unbiased identification of candidates for further qualitative research into intervention design and implementationLarge reductions observed at the CCG level (which are more robust to local circumstances) demonstrate that it is possible to reduce opioid prescribing and that continued and wider success in reducing opioid prescribing is dependent, at least in part, to closing an implementation gapCompeting Interest StatementOver the past five years BG has received research funding from the Laura and John Arnold Foundation, the NHS National Institute for Health Research (NIHR), the NIHR School of Primary Care Research, the NIHR Oxford Biomedical Research Centre, the Mohn-Westlake Foundation, NIHR Applied Research Collaboration Oxford and Thames Valley, the Wellcome Trust, the Good Thinking Foundation, Health Data Research UK (HDRUK), the Health Foundation, and the World Health Organisation; he also receives personal income from speaking and writing for lay audiences on the misuse of science.Funding StatementThis project is funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-0418-20036). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Funders had no role in the study design, collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Original source data for this study have been openly available for many years, currently this is via NHSBSA https://www.nhsbsa.nhs.uk/prescription-data/prescribing-data/english-prescribing-data-epdI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at https://github.com/ebmdatalab/opioids-change-detection-notebook https://github.com/ebmdatalab/opioids-change-detection-notebook CCGclinical commissioning groupsNHSBSANHS Business Services AuthorityOMEoral morphine equivalencePHEPublic Health England